Sionna Therapeutics, Inc. (SION) Balance Sheet
As of 2026-06-30 (10-Q), Sionna Therapeutics, Inc. (SION) reported total assets of $283.2M, total liabilities of $17.5M and shareholders' equity of $265.8M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $63.3M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SIONSionna Therapeutics, Inc.Follow SION — free
—
Price chart with a free account
- Market cap
- 162.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|
| Cash and equivalents | 58.5 | 63.3 | |
| Current assets | 241.4 | 216.1 | |
| Total assets | 326.0 | 283.2 | |
| Current liabilities | 11.7 | 10.8 | |
| Total liabilities | 19.1 | 17.5 | |
| Shareholders' equity | 306.8 | 265.8 |
USD millions · SEC XBRL
Sionna Therapeutics, Inc. — questions
- How much cash does Sionna Therapeutics, Inc. have?
- $63.3M in cash and cash equivalents as of 2026-06-30.
- What are Sionna Therapeutics, Inc.'s total assets?
- $283.2M as of 2026-06-30.
- What is Sionna Therapeutics, Inc.'s shareholders' equity?
- $265.8M as of 2026-06-30.
Every figure on this page comes from Sionna Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.